Skip Navigation

Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more

Francisco Marty, MD


Infectious Disease

Make an Appointment

Physician

  • Associate Professor of Medicine, Harvard Medical School

Centers/Programs

Clinical Interests

  • Cytomegalovirus
  • Novel diagnostics and treatments for invasive fungal disease
  • Respiratory viruses
  • Transplant and oncology infectious diseases

Contact Information

  • Appointments617-632-6064
  • Office Phone Number617-632-6064
  • Fax617-732-6829

Board Certification:

  • Infectious Disease, 2002
  • Internal Medicine, 1999

Fellowship:

  • Brigham and Women's Hospital/Massachusetts General Hospital, Infectious Disease

Residency:

  • Jacobi Medical Center of Albert Einstein College of Medicine, Internal Medicine

Medical School:

  • Universidad Central de Venezuela

Recent Awards:

  • Best Abstracts Award (Clinical Research), American Society for Blood and Marrow Transplantation & Center for International Blood and Marrow Transplant Research, 2012 Tandem Meetings, San Diego, CA. 2012
  • Faculty Teaching Award, Infectious Diseases Fellows, Brigham and Women's Hospital & Massachusetts General Hospital 2010
  • Faculty Mentor Award, Brigham & Women’s Hospital, Department of Medicine. 2010

Research

Marty FM, Lee SJ, Fahey MM, Alyea EP, Soiffer RJ, Antin JH, Baden LR. Infliximab use in patients with severe graft-versus-host disease and other emerging risk factors of non-Candida invasive fungal infections in allogeneic hematopoietic stem cell transplant recipients: a cohort study. Blood. 2003;102(8):2768-76.

2003

Marty FM, Cosimi LA, Baden LR. Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants. N Engl J Med. 2004;350(9):950-2.

2004

Marty FM, Lowry CM, Rodriguez M, Milner DA, Pieciak WS, Sinha A, Fleckenstein L, Baden LR. Treatment of human disseminated strongyloidiasis with a parenteral veterinary formulation of ivermectin. Clin Infect Dis. 2005;41(1):e5-8.

2005

Rodriguez M, Chou S, Fisher DC, Girolami UD, Amato AA, Marty FM. Lyme Meningoradiculitis and Myositis after Allogeneic Hematopoietic Stem Cell Transplantation. Clin Infect Dis. 2005;41(12):e112-4.

2005

Marty FM, Lowry CM, Cutler CS, Campbell BJ, Fiumara K, Baden LR, Antin JH. Voriconazole and Sirolimus Coadministration after Allogeneic Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant. 2006;12(5):552-9.

2006

Martin SI, Marty FM, Fiumara K, Treon SP, Gribben JG, Baden LR. Infectious complications associated with alemtuzumab use for lymphoproliferative disorders. Clin Infect Dis. 2006;43(1):16-24.  

2006

Marty FM, Koo S, Bryar J, Baden LR. (1→3)-beta-D-glucan assay positivity in patients with Pneumocystis (carinii) jiroveci pneumonia. Ann Intern Med. 2007;147(1):70-2.

2007

Seeley WW, Marty FM*, Holmes TM, Upchurch K, Soiffer RJ, Antin JH, Baden LR, Bromfield EB. Post-transplant acute limbic encephalitis: clinical features and relationship to HHV6. Neurology. 2007;69(2):156-65. (*co-first authorship)

2007

Marty FM, Bryar J, Browne SK, Schwarzberg T, Ho VT, Bassett IV, Koreth J, Alyea EP, Soiffer RJ, Cutler CS, Antin JH, Baden LR. Sirolimus-based graft-versus-host disease prophylaxis protects against cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation: a cohort analysis. Blood. 2007;110(2):490-500.

2007

Krause PJ, Gewurz BE, Hill D, Marty FM, Vannier E, Foppa IM, Furman RR, Neuhaus E, Skowron G, Gupta S, McCalla C, Pesanti EL, Young M, Heiman D, Hsue G, Gelfand JA, Wormser GP, Dickason J, Bia FJ, Hartman B, Telford SR, Christianson D, Dardick K, Coleman M, Girotto JE, Spielman A. Persistent and relapsing babesiosis in immunocompromised patients. Clin Infect Dis. 2008;46(3):370-6.

2008

Hammond SP, Borchelt AM, Ukomadu C, Ho VT, Baden LR, Marty FM. Hepatitis B virus reactivation following allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2009;15(9):1049-59.

2009

Kallenberg MH, Gill RR, Factor RE, Bryar JM, Rubin RH, Jacobson FL, Marty FM. Diagnostic Efficacy and Safety of Computed Tomography-guided Transthoracic Needle Biopsy in Patients with Hematologic Malignancies. Acad Radiol. 2009;16(11):1408-15.

2009

Koo S, Bryar JM, Page JH, Baden LR, Marty FM. Diagnostic Performance of the (1→3)-b-D-Glucan Assay for Invasive Fungal Disease. Clin Infect Dis. 2009;49(11):1650-9. 

2009

Koo S, Bryar JM, Baden LR, Marty FM. Prognostic Features of Galactomannan Antigenemia in Galactomannan-Positive Invasive Aspergillosis. J Clin Microbiol. 2010;48(4):1255-60. 

2010

Kubiak DW, Bryar JM, McDonnell AM, Delgado-Flores JO, Mui E, Baden, LR, Marty FM. Evaluation of Caspofungin or Micafungin as Empiric Antifungal Therapy in Adult Patients with Persistent Febrile Neutropenia: A Retrospective, Sequential Cohort Analysis. Clin Ther. 2010;32(4):637-648.

2010

Hammond SP, Marty FM, Bryar JM, DeAngelo DJ, Baden LR. Invasive fungal disease in patients treated for newly diagnosed acute leukemia. Am J Hematol. 2010; 85(9):695-9.

2010

Avery RK, Marty FM, Strasfeld L, Lee I, Arrieta A, Chou S, Tatarowicz W, Villano S. Oral maribavir for treatment of refractory or resistant cytomegalovirus infections in transplant recipients. Transpl Infect Dis. 2010; 12(6):489-96.

2010

Marty FM, Petschnigg EM, Hammond SP, Ready JE, Ho VT, Soiffer RJ, Magee C, Milner DA, Antin JH, Baden LR. Invasive Fungal Disease following Remote Inoculation in Transplantation Recipients. Clin Infect Dis. 2011; 52(1):e7-10.

2011

Issa NC, Marty FM, Gagne LS, Koo S, Verrill KA, Alyea EP, Cutler CS, Koreth J, Armand P, Ho VT, Antin JH, Soiffer RJ, Baden LR. Seroprotective Titers against 2009-H1N1 Influenza A Virus after Vaccination in Allogeneic Hematopoietic Stem Cell Transplantation Recipients. Biol Blood Marrow Transplant. 2011; 17(3):434-8.

2011

Marty FM, Ljungman P, Papanicolaou GA, Winston DJ, Chemaly RF, Strasfeld L, Young JH, Rodriguez T, Maertens J, Schmitt M, Einsele H, Ferrant A, Lipton JH, Villano SA, Chen H, Boeckh M, Maribavir 1263-300 Clinical Study Group. Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplantation: a phase 3, double-blind, placebo-controlled, randomised trial. Lancet Infect Dis. 2011;11(4):284-92.

2011

Herrera AF, Soriano G, Belizzi AM, Hornick JL, Ho VT, Ballen KK, Baden LR, Cutler CS, Antin JH, Soiffer RJ, Marty FM. Cord Colitis Syndrome in Cord-Blood Stem-Cell Transplantation. N Engl J Med. 2011;365(9):315-24.

2011

Chen YB, Driscoll JP, McAfee SL, Spitzer TR, Rosenberg ES, Sanders R, Moss RB, Fang F, Marty FM. Treatment of Parainfluenza 3 Infection with DAS181 in a Patient After Allogeneic Stem Cell Transplantation. Clin Infect Dis. 2011;53(7):e77-e80.

2011

Cornely OA, Marty FM, Stucker F, Pappas PG, Ullmann AJ. Efficacy and safety of micafungin for treatment of serious Candida infections in patients with or without malignant disease. Mycoses 2011; 54(6):e838-47.

2011

Hammond SP, Baden LR, Marty FM. Mortality in Hematologic Malignancy and Hematopoietic Stem Cell Transplant Patients with Mucormycosis 2001-2009. Antimicrob Agents Chemother. 2011;55(11):5018-21.

2011

Issa NC, Koo S, Lynch RC, Gay C, Hammond SP, Baden LR, Ghobrial IM, Finkelman MA, Marty FM. Serum Galactomannan and (1→3) β-D-Glucan Assays in Patients with Multiple Myeloma and Waldenstrom’s Macroglobulinemia. J Clin Microbiol. 2012;50(3):1054-6.

2012

Kubiak DW, Koo S, Hammond SP, Armand P, Baden LR, Antin JH, Marty FM. Safety of Posaconazole and Sirolimus Co-administration in Allogeneic Hematopoietic Stem-Cell Transplantation. Biol Blood Marrow Transplant. 2012;18(9):1462-5.

2012

Hammond SP, Gagne LS, Stock SR, Marty FM, Gelman RS, Marasco WA, Poritz MA, Baden LR. Respiratory Virus Detection in Immunocompromised Patients with FilmArray Respiratory Panel Compared to Conventional Methods. J Clin Microbiol. 2012;50(10):3216-21.

2012

Hill JA, Koo S, Guzman Suarez BB, Ho VT, Cutler C, Koreth J, Armand P, Alyea EP, Baden LR, Antin JH, Soiffer RJ, Marty FM. Cord-blood hematopoietic stem-cell transplantation confers an increased risk for human herpesvirus-6-associated acute limbic encephalitis: a cohort analysis. Biol Blood Marrow Transplant. 2012;18(11):1638-48.

2012

Location

Dana-Farber Cancer Institute
450 Brookline Avenue
Yawkey 8th floor
Boston, MA 02215
Get Directions

Ratings

Top